What are the symptoms of Autoimmune Hepatitis (AIH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Autoimmune Hepatitis (AIH)

The most common symptoms of autoimmune hepatitis include fatigue, jaundice, abdominal pain, and joint pain, though approximately 25-37% of patients may be asymptomatic at diagnosis. 1

Common Presentations

Insidious Onset (Most Common)

  • Fatigue is the predominant complaint in approximately 85% of patients 1
  • General ill health and malaise 1
  • Right upper quadrant abdominal pain 1
  • Lethargy 1
  • Anorexia and weight loss 1
  • Nausea 1
  • Fluctuating jaundice 1
  • Polyarthralgia involving small joints without arthritis 1
  • Amenorrhea in women 1

Asymptomatic Presentation

  • Occurs in 25-37% of patients 1
  • Often discovered incidentally through abnormal liver enzymes 1
  • May develop symptoms within an average of 2 years after diagnosis 1
  • Lower levels of liver enzyme elevation and IgG compared to symptomatic patients 1

Acute Presentation

  • Occurs in approximately 25% of patients 1
  • Can present as:
    • Acute exacerbation of previously undiagnosed chronic AIH 1
    • True acute AIH without chronic histological changes 1
  • May mimic viral or toxic hepatitis 1
  • In acute severe cases, 29-39% may have negative or weakly positive autoantibodies 1
  • Normal serum IgG levels in 25-39% of acute severe cases 1

Fulminant Presentation

  • Occurs in 3-6% of North American and European patients 1
  • Characterized by jaundice with prothrombin time INR ≥2 or development of hepatic encephalopathy 1
  • Heterogeneous hypo-attenuated regions of the liver on non-contrast CT in 65% of cases 1

Physical Examination Findings

  • Physical signs are often absent in early disease 1
  • Hepatomegaly, occasionally painful 1
  • Splenomegaly 1
  • In advanced disease/cirrhosis:
    • Spider nevi 1
    • Palmar erythema 1
    • Caput medusa (dilated periumbilical veins) 1
    • Ascites 1

Associated Conditions

  • Concurrent autoimmune diseases occur in 14-44% of patients 1
  • Common associated conditions:
    • Autoimmune thyroiditis 1
    • Graves' disease 1
    • Synovitis 1
    • Ulcerative colitis 1
    • Type 1 diabetes mellitus (especially in European anti-LKM1+ AIH patients) 1
    • Vitiligo 1
    • Inflammatory bowel disease 1

Special Considerations

Age-Related Differences

  • Patients aged ≥60 years have more autoimmune thyroid and rheumatic diseases than adults ≤30 years (42% versus 13%) 1
  • Young adults more often have inflammatory bowel disease and autoimmune hemolytic anemia (13% versus 0%) 1

Autoantibody-Negative AIH

  • ANA, SMA, and anti-LKM1 are absent in 19-34% of patients initially diagnosed as cryptogenic hepatitis 1
  • In acute severe AIH, autoantibodies may be absent or weakly positive in 29-39% of cases 1

Cirrhosis at Diagnosis

  • Approximately 25-33% of AIH patients have liver cirrhosis at the time of diagnosis regardless of symptoms 1
  • Risk factors for cirrhosis at diagnosis include male gender, black or Hispanic race, older age (≥60 years), and lower education level 1

Atypical Symptoms (Less Common)

  • Pruritus (inconsistent with the diagnosis) 1
  • Hyperpigmentation (inconsistent with the diagnosis) 1
  • Low-grade fever (rare) 1
  • Maculopapular skin rash (rare) 1

Clinical Pitfalls

  • Significant weight loss may suggest a serious complication such as malignancy 1
  • Presence of pruritus or hyperpigmentation is inconsistent with AIH diagnosis and should prompt consideration of other liver diseases 1
  • Asymptomatic patients may still develop symptoms within months to years (range 2-120 months) 1
  • Absence of symptoms should not discourage treatment, as untreated asymptomatic patients have worse 10-year survival than treated symptomatic patients (67% versus 98%) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.